◆ NeutralDASTY

Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

GlobeNewswire Inc.·
Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

Dassault Systèmes completed its $1.8 billion acquisition of ArisGlobal and announced the creation of a unified AI-native platform (3D UNIV+RSES) connecting drug discovery, clinical development, manufacturing, and patient outcomes. Dr. Ashwini Zenooz was appointed as Executive Vice President and CEO of the Life Sciences and Healthcare sector to lead this strategic initiative.

Read Full Article at GlobeNewswire Inc. →
← Back to Financial Intelligence